Related Experiment Video
Updated: May 20, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Machine learning prediction of premature death from multimorbidity among people with inflammatory bowel disease: a
Gemma Postill1, Ijeoma Uchenna Itanyi1, M Ellen Kuenzig1
1Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health (Postill, Harish, Rosella, Benchimol); and Temerty Faculty of Medicine (Postill, Harish, Benchimol), University of Toronto; ICES (Postill, Tang, Buajitti, Rosella, Benchimol); Department of Public Health Sciences, Dalla Lana School of Public Health (Uchenna Itanyi, Buajitti, Rosella), University of Toronto; SickKids Inflammatory Bowel Disease Centre, Division of Gastroenterology, Hepatology and Nutrition (Kuenzig, Tang, Benchimol), and Child Health Evaluative Sciences, SickKids Research Institute (Kuenzig, Tang, Benchimol), The Hospital for Sick Children; Toronto, Ont.; Department of Epidemiology, Biostatistics and Occupational Health (Buajitti), McGill University, Montréal, Que.; Institute for Better Health (Rosella), Trillium Health Partners, Mississauga, Ont.; Department of Paediatrics, Temerty Faculty of Medicine (Benchimol), University of Toronto, Toronto, Ont.
Background:
Multimorbidity, the co-occurrence of 2 or more chronic conditions, is important in patients with inflammatory bowel disease (IBD) given its association with complex care plans, poor health outcomes, and excess mortality. Our objectives were to describe premature death (age < 75 yr) among people with IBD and to identify patterns between multimorbidity and premature death among decedents with IBD.
Methods:
Using the administrative health data of people with IBD who died between 2010 and 2020 in Ontario, Canada, we conducted a population-based, retrospective cohort study. We described the proportion of premature deaths among people with IBD. We developed statistical and machine learning models to predict premature death from the presence of 17 chronic conditions and the patients' age at diagnosis. We evaluated models using accuracy, positive predictive value, sensitivity, F1 scores, area under the receiver operating curve (AUC), calibration plots, and explainability plots.
Results:
All models showed strong performance (AUC 0.81-0.95). The best performing was the model that incorporated age at diagnosis for each chronic condition developed at or before age 60 years (AUC 0.95, 95% confidence interval 0.94-0.96). Salient features for predicting premature death were young ages of diagnosis for mood disorder, osteo-and other arthritis types, other mental health disorders, and hypertension, as well as male sex.
Interpretation:
By comparing results from multiple approaches modelling the impact of chronic conditions on premature death among people with IBD, we showed that conditions developed early in life (age ≤ 60 yr) and their age of onset were important for predicting their health trajectory. Clinically, our findings emphasize the need for models of care that ensure people with IBD have access to high-quality, multidisciplinary health care.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD: